Rapid Progression of Localized Morphea to Disseminated Plaque-Type Morphea Following COVID-19 Infection

Rapid Progression of Localized Morphea to Disseminated Plaque-Type Morphea Following COVID-19 Infection

Authors

  • Hoda Rahimi Skin Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  • Leila Rezaie Shirmard Department of Pharmaceutics, School of Pharmacy, Ardabil University of Medical Sciences, Ardabil, Iran
  • Mehrdad Ashayer Skin Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  • Sajjad Barin Department of Pathology, Ardabil University of Medical Sciences, Ardabil, Iran

Keywords:

COVID-19, morphea, plaque, autoimmune disorders

References

Yazdanpanah N, Rezaei N. Autoimmune complications of COVID-19. J Med Virol. 2022;94(1):54-62. DOI: 10.1002/jmv.27292. PMID: 34427929. PMCID: PMC8661629.

Rahimi H, Tehranchinia Z. A Comprehensive Review of Cutaneous Manifestations Associated with COVID-19. Biomed Res Int. 2020;2020:1236520. DOI: 10.1155/2020/1236520. PMID: 32724793. PMCID: PMC7364232.

Tehranchinia Z, Asadi-Kani Z, Rahimi H. Lichenoid eruptions with interface dermatitis and necrotic subepidermal blister associated with COVID-19. Dermatol Ther. 2020;33(6):e13828. DOI: 10.1111/dth.13828. PMID: 32542925. PMCID: PMC7323232.

Pigliacelli F, Pacifico A, Mariano M, et al. Morphea induced by SARS-CoV-2 infection: A case report. Int J Dermatol. 2021;61(3):377-378. DOI: 10.1111/ijd.15983. PMID: 34783020. PMCID: PMC8653008.

Lotfi Z, Haghighi A, Akbarzadehpasha A, et al. Pansclerotic Morphea Following COVID-19: A Case Report and Review of Literature on Rheumatologic and Non-rheumatologic Dermatologic Immune-Mediated Disorders Induced by SARS-CoV-2. Front Med (Lausanne). 2021;;8:728411. DOI: 10.3389/fmed.2021.728411. PMID: 34746174. PMCID: PMC8564069.

Downloads

Published

2023-04-29

How to Cite

1.
Rahimi H, Rezaie Shirmard L, Ashayer M, Barin S. Rapid Progression of Localized Morphea to Disseminated Plaque-Type Morphea Following COVID-19 Infection. Dermatol Pract Concept. 2023;13(2):e2023075. doi:10.5826/dpc.1302a75

Share